New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo
Hematology&Oncology December 19,2024
Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo
Hematology&Oncology December 19,2024
Cell-based immunotherapy shows promise in early clinical trial for breast cancer

Cell-based immunotherapy shows promise in early clinical trial for breast cancer

byKent State UniversityBreast imaging of one trial patient before (left image) and after (right image) six weeks of experimental immunotherapy. Note diminution of area of disease (dense white ar
Hematology&Oncology December 19,2024
Cell-based immunotherapy shows promise in early clinical trial for breast cancer

Cell-based immunotherapy shows promise in early clinical trial for breast cancer

byKent State UniversityBreast imaging of one trial patient before (left image) and after (right image) six weeks of experimental immunotherapy. Note diminution of area of disease (dense white ar
Hematology&Oncology December 19,2024
New toolkit to support the collection of cancer-patient-reported outcome measures

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac
Hematology&Oncology December 19,2024
New toolkit to support the collection of cancer-patient-reported outcome measures

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac
Hematology&Oncology December 19,2024
Enzyme identified as new therapeutic target for 'cold' tumors

Enzyme identified as new therapeutic target for 'cold' tumors

by Rebecca Dzombak,University of MichiganCredit: Pixabay/CC0 Public DomainA study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunothera
Hematology&Oncology December 19,2024
Enzyme identified as new therapeutic target for 'cold' tumors

Enzyme identified as new therapeutic target for 'cold' tumors

by Rebecca Dzombak,University of MichiganCredit: Pixabay/CC0 Public DomainA study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunothera
Hematology&Oncology December 19,2024
Unraveling the viral puzzle of why humans are susceptible to hepatitis B virus, but monkeys are not

Unraveling the viral puzzle of why humans are susceptible to hepatitis B virus, but monkeys are not

byTokyo University of ScienceStructural comparison of mNTCP and hNTCP. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53533-6Hepatitis B virus (HBV) infection is a leadi
Hepatobiliary&Pancreas Surgery December 19,2024
Unraveling the viral puzzle of why humans are susceptible to hepatitis B virus, but monkeys are not

Unraveling the viral puzzle of why humans are susceptible to hepatitis B virus, but monkeys are not

byTokyo University of ScienceStructural comparison of mNTCP and hNTCP. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53533-6Hepatitis B virus (HBV) infection is a leadi
Hepatobiliary&Pancreas Surgery December 19,2024
Scientists identify brain cell type as master controller of urination

Scientists identify brain cell type as master controller of urination

by Emily Packer, George Litchfield,eLifePMCESR1+cells tightly correlate with successful voiding. Credit:eLife(2024). DOI: 10.7554/eLife.103224.1Researchers have identified a su
Nephrology & Urology December 19,2024
Scientists identify brain cell type as master controller of urination

Scientists identify brain cell type as master controller of urination

by Emily Packer, George Litchfield,eLifePMCESR1+cells tightly correlate with successful voiding. Credit:eLife(2024). DOI: 10.7554/eLife.103224.1Researchers have identified a su
Nephrology & Urology December 19,2024
Scientists discover new receptor for nerve growth factor—a promising target for treating pain

Scientists discover new receptor for nerve growth factor—a promising target for treating pain

byNew York UniversityNerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Credit: Bunnett LabResearchers at the NYU Pain
Neurology December 19,2024
Scientists discover new receptor for nerve growth factor—a promising target for treating pain

Scientists discover new receptor for nerve growth factor—a promising target for treating pain

byNew York UniversityNerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Credit: Bunnett LabResearchers at the NYU Pain
Neurology December 19,2024
Discontinuing cholinesterase when starting memantine not tied to institutionalization care

Discontinuing cholinesterase when starting memantine not tied to institutionalization care

by Lori SolomonDiscontinuing cholinesterase inhibitors upon memantine initiation is not associated with an increased risk for long-term care institutionalization among older adults with dementia, acco
Neurology December 19,2024
Discontinuing cholinesterase when starting memantine not tied to institutionalization care

Discontinuing cholinesterase when starting memantine not tied to institutionalization care

by Lori SolomonDiscontinuing cholinesterase inhibitors upon memantine initiation is not associated with an increased risk for long-term care institutionalization among older adults with dementia, acco
Neurology December 19,2024
Gut microbiota: A consensus paper to regulate the 'wild west' of diagnostic tests

Gut microbiota: A consensus paper to regulate the 'wild west' of diagnostic tests

byCatholic University of the Sacred HeartCredit: CC0 Public DomainThe gut microbiota might perhaps one day become a routine tool for the early diagnosis of many diseases and to guide treatment,
Gastroenterology December 19,2024
Gut microbiota: A consensus paper to regulate the 'wild west' of diagnostic tests

Gut microbiota: A consensus paper to regulate the 'wild west' of diagnostic tests

byCatholic University of the Sacred HeartCredit: CC0 Public DomainThe gut microbiota might perhaps one day become a routine tool for the early diagnosis of many diseases and to guide treatment,
Gastroenterology December 19,2024
New method of drug discovery and development offers better understanding of how drugs work

New method of drug discovery and development offers better understanding of how drugs work

byKarolinska InstitutetCeTEAM is predicated on stability-dependent biosensors to measure drug binding. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54415-7According to
Drug Discovery December 19,2024
New method of drug discovery and development offers better understanding of how drugs work

New method of drug discovery and development offers better understanding of how drugs work

byKarolinska InstitutetCeTEAM is predicated on stability-dependent biosensors to measure drug binding. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54415-7According to
Drug Discovery December 19,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com